* Apollo Medical Holdings Inc AMEH.OQ AMEH.O is expected
to show a rise in quarterly revenue when it reports results on
August 7.
* The Alhambra California-based company is expected to
report a
26.8% increase in revenue to $341.969 million from $269.7
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Apollo Medical
Holdings
Inc is for earnings of 25 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Apollo
Medical
Holdings Inc is $52, above its last closing price of $34.76.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 0.31 0.31 0.31 Met 1.1
Dec. 31 2023 -0.11 -0.09 -0.06 Beat 33.3
Sep. 30 2022 0.31 0.32 0.56 Beat 75.8
Jun. 30 2022 0.20 0.20 0.25 Beat 23.2
Mar. 0.32 0.32 0.31 Missed -3.1
31 2022
Dec. 31 2021 0.26 0.27 0.30 Beat 13.2
Sep. 30 2021 0.34 0.34 0.69 Beat 102.9
Jun. 30 2021 0.21 0.21 0.28 Beat 33.3
This summary was machine generated July 31 at 13:37 GMT. All
figures in US dollars unless otherwise stated